Creative Biogene-Mitochondrial Research news

Creative Biogene today released comprehensive mitochondrial gene expression services with streamlined project procedures and high-standard mtDNA expression results.

"For years, we have been engaged in the mitochondrial study. Our scientists explore mitochondrial gene expression via mtDNA microarray expression profiling, gene chip data mining, key gene & protein verification, and functional gene synthesis. In the meantime, our end goal is to develop a complete, high-st

Creative Biogene unveiled a rich portfolio of efficient cell apoptosis assay kits targeted to detect mitochondrial permeability transition pore (MPTP) as well as mitochondrial membrane potential (MMP) to assist researchers in mitochondrial studies.

Mitochondrial dysfunction has been linked to a variety of market therapeutics and pathological diseases. Therefore, studying or maintaining mitochondrial health is paramount to cell health. Creative Biogene's cell apoptosis ass

New York, United States—June 28, 2022—Creative Biogene offers one-stop mitochondria-focused testing services for the evaluation of a variety of cardiac diseases associated with mitochondrial dysfunction, which can provide insights and potential treatments for mitochondrial disorders in the preclinical stages. With its ready-to-use models and assays for cardiac diseases, customers can accurately analyze the relationship between diseases and mitochondria.

Mitochondri

New York, United States—May 18, 2022—As one of leading bio-companies engaged in mitochondrial research, Creative Biogene, together with its large team of experts, create a powerful mitochondrial research service platform. To satisfy the research needs of global customers on mitochondrial bioenergies, Creative Biogene provides partners with comprehensive range of mitochondrial bioenergetics detection and analysis services based on years of experience and high-end instruments.

&n

New York, United States—April 21, 2022—Defects in mitochondrial function have long been suspected of contributing to the development of cancer. In this regard, Creative Biogene strives to explore mitochondrial functions that are yet to be discovered as well as the pathogenesis of mitochondria-associated cancers and possible interventions through in-depth mitochondrial function testing to accelerate the preclinical development of novel drugs and therapy targeted to cancer.